Muhammet Tanc

Muhammet Tanc, PhD, is Co-Founder & CEO of Nuclide Therapeutics, a biotech company developing next-generation radiotheranostics for therapy-resistant cancers. With over 15 years of experience in cancer drug development across academia and translational research, he works at the intersection of drug discovery, radiopharmaceutical innovation, and clinical translation. He is focused on building science-driven programmes into clinically impactful, investable companies.